Tourangeau Greg 4
4 · Fulcrum Therapeutics, Inc. · Filed Feb 13, 2023
Insider Transaction Report
Form 4
Tourangeau Greg
Principal Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-09+16,100→ 16,100 totalExercise: $12.59Exp: 2033-02-08→ Common Stock (16,100 underlying)
Footnotes (1)
- [F1]This option was granted on February 9, 2023 and is is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2023, subject to the reporting person's continued service on each such vesting date.